...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group 'Laboratory Error and Patient Safety' and EFLM Task and Finish Group 'Performance specifications for the extra-analytical phases'
【24h】

Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group 'Laboratory Error and Patient Safety' and EFLM Task and Finish Group 'Performance specifications for the extra-analytical phases'

机译:定义用于协调实验室药物质量指标的路线图:代表IFCC工作组“实验室误差和患者安全”和EFLM任务和终结组的共识声明,为额外分析阶段进行绩效规范“

获取原文
获取原文并翻译 | 示例
           

摘要

The improving quality of laboratory testing requires a deep understanding of the many vulnerable steps involved in the total examination process (TEP), along with the identification of a hierarchy of risks and challenges that need to be addressed. From this perspective, the Working Group "Laboratory Errors and Patient Safety" (WG-LEPS) of International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) is focusing its activity on implementation of an efficient tool for obtaining meaningful information on the risk of errors developing throughout the TEP, and for establishing reliable information about error frequencies and their distribution. More recently, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has created the Task and Finish Group "Performance specifications for the extra-analytical phases" (TFG-PSEP) for defining performance specifications for extra-analytical phases. Both the IFCC and EFLM groups are working to provide laboratories with a system to evaluate their performances and recognize the critical aspects where improvement actions are needed. A Consensus Conference was organized in Padova, Italy, in 2016 in order to bring together all the experts and interested parties to achieve a consensus for effective harmonization of quality indicators (QIs). A general agreement was achieved and the main outcomes have been the release of a new version of model of quality indicators (MQI), the approval of a criterion for establishing performance specifications and the definition of the type of information that should be provided within the report to the clinical laboratories participating to the QIs project.
机译:改善实验室测试的质量需要深入了解总审查过程中涉及的许多易受攻击的步骤(TEP),以及确定需要解决的风险和挑战的等级。从这个角度来看,国际临床化学和实验室医学联合会(IFCC)的“实验室错误和患者安全”(WG-LEP)将其在实施有关错误风险的有意义信息的有效工具的活动在整个TEP中开发,并建立有关误差频率及其分发的可靠信息。最近,欧洲临床化学和实验室医学联合会(EFLM)已经为定义了分析阶段的性能规范来创造了任务和终点“(TFG-PSEP)的任务和完成组”性能规范“。 IFCC和EFLM组都正致力于为实验室提供系统,以评估其性能并识别所需行动的关键方面。 2016年帕多瓦举办了一项协商一致会议,以便将所有专家和有关各方汇集在一起​​,以实现有效协调质量指标(QIS)的共识。实现了一般协议,主要结果一直是发布新版本的质量指标模型(MQI),批准建立绩效规范的标准以及应在报告中提供的信息类型的定义参加QIS项目的临床实验室。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号